There are many therapies on the map of current available treatment options in MS. They differ in their mechanism of action, and thus in their effect on our immune system. We can expect a different response from short-acting drugs, and another from drugs whose mechanism of action is not rapidly reversible.
"Most new and expected therapies have been introduced into the drug program. Treatment eligibility criteria for highly active therapies have been relaxed, and botulinum toxin for the treatment of spasticity has been added to the fall list. This is a huge range of therapeutic possibilities, which requires knowledge of how to design treatment in the context of the patient's entire life. Wanting to be co-responsible for the choice of therapy, and thus participating in decisions about our own health, let's not be afraid and ask questions!"- says Malina Wieczorek, president of the MS-walcz o siebie Foundation.
Already during a recent social survey conducted by the Maison&Partners Research House for the MS-Fight for Yourself Foundation, on a group of 942 people with MS, respondents indicated the key role of doctors in expanding their knowledge of the disease. The majority of respondents rate the...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
